Related topics: Globalisation, Industry Drivers
Merck & Co is investing an additional €20m ($27m) in its biologics plant in Carlow, Ireland just weeks after it unveiled plans to create a “powerful biologics presence” through its $41bn move for fellow US drug giant Schering-Plough.
According to reports in the Irish media, the extra funds bring Merck’s total investment in the facility to €220m and create an additional 160 construction jobs.
In October last year when construction at the Carlow began, Merck announced that the plant be used for the formulation and filling of biologic drugs and vaccine products and employ a staff of 170 when fully operational in 2011.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
